Back
Ardelyx Vs. Enanta Pharmaceuticals Industry Stock Comparison
Sell
50
ARDX
Ardelyx
Last Price:
6.13
Seasonality Move:
21.94%
Sell
26
ENTA
Enanta Pharmaceuticals
Last Price:
11.29
Seasonality Move:
3.99%
Sell
50
Ardelyx (ARDX)
is a Sell
Is Ardelyx a Buy, Sell or Hold?
- The current Ardelyx [ARDX] share price is $6.14. The Score for ARDX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- ARDX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
26
Enanta Pharmaceuticals (ENTA)
is a Sell
Is Enanta Pharmaceuticals a Buy, Sell or Hold?
- The current Enanta Pharmaceuticals [ENTA] share price is $11.28. The Score for ENTA is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- ENTA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ARDX Stock Price Chart
ENTA Stock Price Chart
What is Enanta Pharmaceuticals's stock price today?
-
The Enanta Pharmaceuticals share price today is $11.28
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENTA is experiencing slight buying pressure.
ARDX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 53.84 | Buy |
| Chaikin Money Flow: | 936276 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.79 - 6.27) | Buy |
| Bollinger Bands (100): | (5.5 - 7.26) | Sell |
ENTA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.44 | Sell |
| Relative Strength Index (14 RSI): | 36.07 | Sell |
| Chaikin Money Flow: | 3002 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.68 - 12.88) | Sell |
| Bollinger Bands (100): | (11.89 - 14.27) | Sell |
ARDX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.11 | Buy |
| 20-day SMA: | 6.02 | Buy |
| 50-day SMA: | 5.88 | Buy |
| 200-day SMA: | 7.05 | Sell |
| 8-day EMA: | 6.05 | Buy |
| 20-day EMA: | 6 | Buy |
| 50-day EMA: | 6.03 | Buy |
| 200-day EMA: | 6.24 | Sell |
ENTA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.76 | Sell |
| 20-day SMA: | 12.22 | Sell |
| 50-day SMA: | 13.25 | Sell |
| 200-day SMA: | 12.99 | Sell |
| 8-day EMA: | 11.64 | Sell |
| 20-day EMA: | 12.07 | Sell |
| 50-day EMA: | 12.68 | Sell |
| 200-day EMA: | 14.27 | Sell |
Ardelyx Earnings Growth & ARDX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.03 per share, a decrease this year of $0.02 per share, and an increase next year of $0.14 per share.
Enanta Pharmaceuticals Earnings Growth & ENTA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.25 per share, an increase this year of $2.01 per share, and an increase next year of $0.23 per share.
Ardelyx Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Enanta Pharmaceuticals Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||